Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:820-827
Published online before print February 5, 2004, doi: 10.1161/01.RES.0000120863.53562.DF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
94/6/820    most recent
01.RES.0000120863.53562.DFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanza, R.
Right arrow Articles by Anversa, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanza, R.
Right arrow Articles by Anversa, P.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Other myocardial biology
Right arrow Animal models of human disease
Right arrow Cell biology/structural biology
(Circulation Research. 2004;94:820.)
© 2004 American Heart Association, Inc.


Integrative Physiology

Regeneration of the Infarcted Heart With Stem Cells Derived by Nuclear Transplantation

Robert Lanza, Malcolm A.S. Moore, Teruhiko Wakayama, Anthony C.F. Perry, Jae-Hung Shieh, Jan Hendrikx, Annarosa Leri, Stefano Chimenti, Alyssa Monsen, Daria Nurzynska, Michael D. West, Jan Kajstura, Piero Anversa

From Advanced Cell Technology (R.L., M.D.W.), Worcester, Mass; Laboratory of Developmental Hematopoiesis (M.A.S.M., J.-H.S., J.H.), Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY; Laboratory for Genomic Reprogramming (T.W.) and Laboratory of Mammalian Molecular Embryology (A.C.F.P.), RIKEN Center for Developmental Biology, Kobe, Japan; and the Cardiovascular Research Institute (A.L., S.C., A.M., D.N., J.K., P.A.), Department of Medicine, New York Medical College, Valhalla, NY.

Correspondence to Piero Anversa, MD, Cardiovascular Research Institute, Department of Medicine, New York Medical College, Valhalla, NY. E-mail piero_anversa{at}nymc.edu

Nuclear transfer techniques have been proposed as a strategy for generating an unlimited supply of rejuvenated and histocompatible stem cells for the treatment of cardiac diseases. For this purpose, c-kit–positive fetal liver stem cells obtained from cloned embryos were injected in the border zone of infarcted mice to induce tissue reconstitution. Cloned embryos were derived from somatic cell fusion between nuclei of cultured LacZ-positive fibroblasts and enucleated oocytes of a different mouse strain. We report that regenerating myocardium replaced 38% of the scar at 1 month. The rebuilt tissue expressed LacZ and was composed of myocytes and vessels connected with the coronary circulation. Myocytes were functionally competent and expressed contractile proteins, desmin, connexin43, and N-cadherin. These structural characteristics indicated that the new myocytes were electrically and mechanically coupled. Similarly, the formed coronary arterioles and capillary structures contained blood and contributed, therefore, to tissue oxygenation. Cardiac replacement resulted in an improvement of ventricular hemodynamics and in a reduction of diastolic wall stress. These beneficial effects were obtained by stem cell transdifferentiation and commitment to the cardiac cell lineages. Myocardial growth was independent from fusion of the injected stem cells with preexisting partner cells. In conclusion, c-kit–positive stem cells derived by nuclear transfer cloning restore infarcted myocardium. Although problems currently plague nuclear transplantation, including the potential for epigenetic and imprinting abnormalities, stem cells derived from cloned embryos are sufficiently normal to repair damaged tissue in vivo. Importantly, the magnitude of myocardial regeneration obtained in this study is significantly superior to that achieved with adult bone marrow cells.


Key Words: fetal stem cells • cardiac repair • new coronary arterioles • cardiomyocytes




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. R. Crisostomo, A. M. Abarbanell, M. Wang, T. Lahm, Y. Wang, and D. R. Meldrum
Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1726 - H1735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. S. Jovin and F. J. Giordano
Differentiation by association: is a cell's fate determined by the company it keeps?
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1503 - H1504.
[Full Text] [PDF]


Home page
CirculationHome page
P. Oettgen
Cardiac Stem Cell Therapy: Need for Optimization of Efficacy and Safety Monitoring
Circulation, July 25, 2006; 114(4): 353 - 358.
[Full Text] [PDF]


Home page
Hum ReprodHome page
B. C. Heng and G. Q. Tong
Mirror exchange of donor gametes should also accommodate scientific research.
Hum. Reprod., April 1, 2006; 21(4): 1100 - 1100.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. B. Ayach, M. Yoshimitsu, F. Dawood, M. Sun, S. Arab, M. Chen, K. Higuchi, C. Siatskas, P. Lee, H. Lim, et al.
Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction
PNAS, February 14, 2006; 103(7): 2304 - 2309.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Eschenhagen and W. H. Zimmermann
Engineering Myocardial Tissue
Circ. Res., December 9, 2005; 97(12): 1220 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ausoni, T. Zaglia, A. Dedja, R. Di Lisi, M. Seveso, E. Ancona, G. Thiene, E. Cozzi, and S. Schiaffino
Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants
Cardiovasc Res, December 1, 2005; 68(3): 394 - 404.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Leri, J. Kajstura, and P. Anversa
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
Physiol Rev, October 1, 2005; 85(4): 1373 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
J. C Chachques, C. Salanson-Lajos, P. Lajos, A. Shafy, A. Alshamry, and A. Carpentier
Cellular Cardiomyoplasty for Myocardial Regeneration
Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 287 - 296.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. C. Wollert and H. Drexler
Clinical Applications of Stem Cells for the Heart
Circ. Res., February 4, 2005; 96(2): 151 - 163.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kajstura, M. Rota, B. Whang, S. Cascapera, T. Hosoda, C. Bearzi, D. Nurzynska, H. Kasahara, E. Zias, M. Bonafe, et al.
Bone Marrow Cells Differentiate in Cardiac Cell Lineages After Infarction Independently of Cell Fusion
Circ. Res., January 7, 2005; 96(1): 127 - 137.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. M. Regula, M. J. Rzeszutek, D. Baetz, C. Seneviratne, and L. A. Kirshenbaum
Therapeutic opportunities for cell cycle re-entry and cardiac regeneration
Cardiovasc Res, December 1, 2004; 64(3): 395 - 401.
[Abstract] [Full Text] [PDF]